C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1998
10/01/1998	WO1998042738A1 87 human secreted proteins
10/01/1998	WO1998042737A2 Peptides for the treatment of systemic lupus erythematosus
10/01/1998	WO1998042736A1 Diagnosis of colorectal cancer and proteins and antibodies for use therein
10/01/1998	WO1998042735A1 Novel monomer elements for marking peptidic nucleic acids
10/01/1998	WO1998042733A1 uPAR MIMICKING PEPTIDE
10/01/1998	WO1998042731A1 Glycoprotein for the protection of liposomes
10/01/1998	WO1998042726A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/01/1998	WO1998042725A1 Methods and compositions for diagnosis and treatment of breast cancer
10/01/1998	WO1998042724A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/01/1998	WO1998042723A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/01/1998	WO1998042722A1 Antisense inhibition of angiogenin expression
10/01/1998	WO1998042375A1 Detoxified mutants of bacterial adp-ribosylating toxins as parenteral adjuvants
10/01/1998	WO1998042372A1 CARBOHYDRATE ANTIGENS WHICH IMMUNOREACT WITH POLYCLONAL ANTISERA AGAINST $i(H. PYLORI)
10/01/1998	WO1998042365A1 Ligand/lytic peptide compositions and methods of use
10/01/1998	WO1998042364A1 Ligand/lytic peptide compositions and methods of use
10/01/1998	WO1998042354A1 Chemokines that inhibit immunodeficiency virus infection and methods based thereon
10/01/1998	WO1998042315A1 Identification of the progression elevated gene-3 and uses thereof
10/01/1998	WO1998042296A2 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
10/01/1998	WO1998042189A1 POLYPEPTIDES WHICH IMMUNOREACT WITH POLYCLONAL ANTISERA AGAINST $i(H. PYLORI)
10/01/1998	WO1998029555A3 Cytopathic viruses for therapy and prophylaxis of neoplasia
10/01/1998	WO1998027206A3 POLYPEPTIDES OF THE 'BASIC-HELIX-LOOP-HELIX' bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES
10/01/1998	WO1998027200A3 Human and mammalian dna replication origin consensus sequences
10/01/1998	WO1998024896A3 Muteins of obese protein
10/01/1998	WO1998024811A3 Vascular endothelial growth factor
10/01/1998	WO1998022580A3 Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
10/01/1998	WO1998021239A3 Therapeutic compositions and methods and diagnostic assays for type ii diabetes involving hnf-1
10/01/1998	WO1998007835A3 Crystal structures of a protein tyrosine kinase
10/01/1998	DE19727814C1 Monoclonal antibody specific for human tyrosine kinase receptor protein
10/01/1998	DE19713001A1 Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung Graminaenpollenallergenmutanten for specific immunotherapy, their preparation and use
10/01/1998	DE19712530A1 Neue Monomerbausteine zur Markierung von peptidischen Nukleinsäuren New monomer to mark peptide nucleic acids
10/01/1998	CA2287082A1 Iron hydrolyzates of casein complexes and processes for preparation thereof
10/01/1998	CA2285702A1 Anticoagulant fusion protein anchored to cell membrane
10/01/1998	CA2285694A1 Process for preparing obesity protein analogs
10/01/1998	CA2285675A1 Pan-bacterial and pan-fungal identification reagents and methods of use thereof
10/01/1998	CA2285554A1 Secreted proteins and polynucleotides encoding them
10/01/1998	CA2285533A1 Methods for screening for antimicrobials utilizing (aarc) and compositions thereof
10/01/1998	CA2285413A1 Tissue specific promoters
10/01/1998	CA2285017A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/01/1998	CA2285015A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/01/1998	CA2285013A1 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
10/01/1998	CA2284844A1 A porin gene from campylobacter jejuni, related products and uses thereof
10/01/1998	CA2284735A1 A transgenic model of colon cancer and anal cancer
10/01/1998	CA2284685A1 Noey2 gene compositions and methods of use
10/01/1998	CA2284671A1 Carbohydrate antigens which immunoreact with polyclonal antisera against h. pylori
10/01/1998	CA2284642A1 Methods and compositions for diagnosis and treatment of breast cancer
10/01/1998	CA2284633A1 Chemokines that inhibit immunodeficiency virus infection and methods based thereon
10/01/1998	CA2284550A1 87 human secreted proteins
10/01/1998	CA2284272A1 Diagnosis of epithelial cell abnormalities
10/01/1998	CA2284251A1 Compounds and methods for the diagnosis and treatment of ehrlichia infection
10/01/1998	CA2284105A1 Synthetic saposin c-derived neurotrophic peptides
10/01/1998	CA2284104A1 Chlorella virus promoters
10/01/1998	CA2284095A1 Bi- or multifunctional molecules based on a dendroaspin scaffold
10/01/1998	CA2283932A1 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions
10/01/1998	CA2283794A1 Vp22 proteins and uses thereof
10/01/1998	CA2283792A1 Peptides for the treatment of systemic lupus erythematosus
10/01/1998	CA2283705A1 Zinc free insulin crystals for use in pulmonary compositions
10/01/1998	CA2283640A1 Diagnosis of colorectal cancer and proteins and antibodies for use therein
10/01/1998	CA2283635A1 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying
10/01/1998	CA2283631A1 Secreted proteins and polynucleotides encoding them
10/01/1998	CA2282715A1 Plants with modified growth
10/01/1998	CA2282410A1 Monoclonal antibodies to human cd6
10/01/1998	CA2256599A1 Iron-casein complex and process for preparing the same
10/01/1998	CA2255765A1 Antigenic fusionprotein carrying gal.alpha.1,3gal epitopes
10/01/1998	CA2247075A1 Interferon related protein hkafe42
10/01/1998	CA2233783A1 Anti-fas antibodies
09/1998
09/30/1998	EP0867514A2 Enhanced protein production method
09/30/1998	EP0867510A1 Method of preparing plasmid having both expressing ability of retroviral gene and processing ability after translation, and resultant plasmid and expression products thereof
09/30/1998	EP0867509A2 Tumor necrosis related receptor, TR5
09/30/1998	EP0867508A2 Olfactory receptor of the 7-transmembrane receptor family - OLRCC15 receptor
09/30/1998	EP0867507A1 LicB polypeptides from Streptococcus pneumoniae
09/30/1998	EP0867450A1 Novel peptide
09/30/1998	EP0867449A1 Cell adhesion protein, immunosuppressive agent containing the same, and immunosuppressive agent containing cells induced thereby
09/30/1998	EP0867448A1 PEPTIDE SUPPRESSING IxB$g(a) PHOSPHORYLATION
09/30/1998	EP0867189A2 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
09/30/1998	EP0866878A1 Detection of mammary tumor virus-like sequences in human breast cancer
09/30/1998	EP0866872A1 A FUNGUNS WHEREIN THE areA, pepC AND/OR pepE GENES HAVE BEEN INACTIVATED
09/30/1998	EP0866871A1 Compositions and method for stimulating antibody release by b lymphocytes
09/30/1998	EP0866870A1 TISSUE FACTOR - KUNITZ DOMAIN FUSION PROTEINS AS FACTOR VIIa INHIBITORS
09/30/1998	EP0866864A2 Antifungal proteins
09/30/1998	EP0866863A1 Antifungal proteins
09/30/1998	EP0866862A1 Process for the purification of recombinant human interleukin-8
09/30/1998	EP0866861A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands
09/30/1998	EP0866860A2 Novel tyrosine kinase receptors and ligands
09/30/1998	EP0866859A1 Urogenital sinus derived growth factor nucleotide and amino acid sequences
09/30/1998	EP0866858A1 Huntingtin-associated protein
09/30/1998	EP0866857A1 E6 binding proteins
09/30/1998	EP0866856A1 Crf analogs and their use in photoaffinity labeling of crf receptors
09/30/1998	EP0866851A1 Tumour vaccine and process for the preparation thereof
09/30/1998	EP0866806A1 Method of mobilizing hematopoietic stem cells
09/30/1998	EP0866805A1 PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
09/30/1998	EP0866804A2 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action
09/30/1998	EP0866803A1 Transferrin receptor protein of moraxella
09/30/1998	EP0866802A1 Multivalent polymers, processes for their preparation, and their use for preparing biologically active compounds.
09/30/1998	EP0866799A1 Apolipoprotein e2 and treatment of alzheimer's disease
09/30/1998	EP0866721A1 Targeted adenovirus vectors
09/30/1998	EP0866720A1 Methods of increasing lean tissue mass using ob protein compositions
09/30/1998	EP0866719A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product
09/30/1998	EP0866718A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells
09/30/1998	EP0866717A1 Oligodendrocyte-specific protein and method for treating disease
09/30/1998	EP0781092A4 Method of sensitizing tumor cells with adenovirus e1a

1 ... 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 ... 2916